Tag Archives: prxl

Parexel Lowers Guidance On Restructuring, Stock Falls

Clinical research organization Parexel International (PRXL) plunged more than 7% Wednesday, off record highs, after it lowered its guidance late Tuesday ahead of its investor day. Parexel said it now expects revenue for the fiscal Q4 ending June 30 to be $517 million to $533 million, down from its previous guidance of $520 million to $540 million. Earnings will be taking a hit in the range of $20 to $30 million, lowering GAAP EPS guidance by about

Parexel Defended After Post-Guidance Sell-Off

Contract research organization Parexel International (PRXL) got a pair of upgrades Thursday after its stock sold off Wednesday following the company’s 2015 guidance. Investors still seemed undecided, however, as the stock opened up 6% but backtracked to a gain of less than 3%, near 53.25, in midday trading in the stock market today. Ahead of its annual investor day on Wednesday, Parexel affirmed its guidance for fiscal 2014, which ends June 30,

Akorn, Questcor, Parexel Among Top Medical Small Caps

The health care industry is rapidly changing with new advances in medicine. Many of the most promising novel advancements are coming from smaller companies, which are more nimble and quicker to change. Medicine and health care-related stocks Akorn (AKRX), Questcor Pharmaceuticals (QCOR), Parexel International (PRXL), and Medidata Solutions (MDSO) are highly ranked companies featured in the Screen of the Day. The Small-Cap Leaders screen features